way beyond $0.1... Smart money loading, as $$$ p.p.s.written all over it and Todos Medical will be on NASDAQ OR NYSE late 2021, here is why: DEC/1/2020 Todos recently completed the installation of two (2) Tecan® liquid handlers at its largest lab client in Wisconsin... Additionally, we are preparing to complete the installation of a similar lab automation workflow process at another lab in Brooklyn, NY in the month of December... https://www.otcmarkets.com/stock/TOMDF/news/Todos-Medical-Provides-Strategic-Outlook?id=282044
Todos expects revenue growth for December 2020, as daily testing volumes for the majority of its COVID-19 testing clients increases sequentially on a weekly basis.
"We intend to focus our pipeline initially on breast cancer where we are building up significant intellectual property around our proprietary TBIA/FTIR platform, and commercial infrastructure by way of the strategic acquisition of Provista Diagnostics, so that we can consolidate our commercial opportunity and optimize assay performance as we go to market in 2021 in breast cancer blood testing".